Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines. | Antioxidants (Basel) | 2023 | 36830074 | PubTator, text mining | PubMed |
| Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity. | J Endocrinol Invest | 2023 | 36828986 | PubTator, text mining | PubMed |
| Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody. | Nat Commun | 2023 | 36828835 | PubTator, text mining | PubMed |
| PNPLA3 148M/M Is More Susceptible to Palmitic Acid-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells. | Int J Endocrinol | 2023 | 36825197 | PubTator, text mining | PubMed |
| Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. | Nat Biotechnol | 2023 | 36823355 | PubTator, text mining | PubMed |
| MBOAT7 rs641738 variant in metabolic-dysfunction-associated fatty liver disease and cardiovascular risk. | Med Pharm Rep | 2023 | 36818318 | PubTator, text mining | PubMed |
| Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases. | Front Med (Lausanne) | 2023 | 36817797 | PubTator, text mining | PubMed |
| Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities. | Aliment Pharmacol Ther | 2023 | 36815445 | PubTator, text mining | PubMed |
| Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants. | Hepatol Int | 2023 | 36809487 | PubTator, text mining | PubMed |
| Multivariate GWAS analysis reveals loci associated with liver functions in continental African populations. | PLoS One | 2023 | 36809439 | PubTator, text mining | PubMed |
Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis. | Tumour Virus Res | 2023 | 36804832 | PubTator, text mining | PubMed |
| The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. | BMC Med | 2023 | 36800955 | PubTator, text mining | PubMed |
| p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling. | Hepatology | 2023 | 36799449 | PubTator, text mining | PubMed |
| Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease. | Int J Med Sci | 2023 | 36794157 | PubTator, text mining | PubMed |
| Interactions between genetic and lifestyle factors on cardiometabolic disease-related outcomes in Latin American and Caribbean populations: A systematic review. | Front Nutr | 2023 | 36776603 | PubTator, text mining | PubMed |
| Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death. | Front Cell Dev Biol | 2023 | 36776554 | PubTator, text mining | PubMed |
| Acute and long-term exercise adaptation of adipose tissue and skeletal muscle in humans: a matched transcriptomics approach after 8-week training-intervention. | Int J Obes (Lond) | 2023 | 36774413 | PubTator, text mining | PubMed |
| Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. | Nutrients | 2023 | 36771394 | PubTator, text mining | PubMed |
| Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study. | J Clin Med | 2023 | 36769628 | PubTator, text mining | PubMed |
| The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH. | Int J Mol Sci | 2023 | 36768654 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=45